Parent-led communication program for young children with cochlear implants and hearing loss
Tests a parent-taught communication program in children with cochlear implants for hearing loss.
Key facts
- Who runs it
- Ann & Robert H Lurie Children's Hospital of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- Neural Prediction to Enhance Language
- Status
- Recruiting
- People taking part
- 700 people, planned
- Started
- 23 Jan 2023
- Expected to end
- 23 Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Parent-Implemented Communication Treatment
- Record updated
- 2 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young children with hearing loss in both ears who can have cochlear implants. It studies brain scans to predict language growth, and a parent training program.
- Age
- 0 Months to 5 Years. Group 1: age 5 years and under when implant evaluation begins. Group 2: implanted at 36 months or younger when treatment begins.
- Sex
- All
- Disease stage
- Sensorineural hearing loss (inner ear or nerve hearing loss) in both ears that meets clinical criteria for cochlear implants.
- Earlier treatment
- Group 2: children cannot join if they have used a cochlear implant (CI) for more than two months before treatment starts.
- Biomarker or test result
- Group 2: children who already speak and score better than the 25th percentile on the Words and Sentences part of the CDI language test cannot join.
Main reasons for not taking part
- Severe motor or thinking disability that would prevent measuring progress
- Limited electrode insertion likely to strongly affect hearing speech
- Hearing loss caused by bacterial meningitis
- Home language not English or Spanish (Group 2: not English)
- Group 2: cochlear nerve deficiency, severe cochlear malformation, or other conditions that affect language apart from hearing loss
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Children with sensorineural hearing loss who meet clinical criteria for cochlear implantation in both ears who meet the following age criteria at time cochlear implant evaluation begins:; Age 5 years and under; English or Spanish as the dominant language
- English or Spanish dominant language in the home
- Children with bilateral sensorineural hearing loss who meet clinical criterial for cochlear implantation
- English dominant spoken language by family
- Age at implantation of 36 months and younger when treatment begins
- Parent or caregiver that is willing to participate who understands spoken English
- Child is exposed to spoken language by at least one parent (total communication or auditory/oral) in the home
Who cannot take part
- Child with more than two months CI experience prior to start of treatment
- Diagnoses or medical conditions expected to impact language development independent of hearing loss
- Severe motor and /or cognitive disability that would preclude evaluation of progress
- Limited electrode insertion likely to significantly impact development of speech perception
- Hearing loss due to bacterial meningitis
- Neither English or Spanish as the dominant family language in the home
- Severe motor and /or cognitive disability that would preclude evaluation of progress
- Limited electrode insertion likely to significantly impact development of speech perception
- Hearing loss due to bacterial meningitis
- Dominant language other than English
- Cochlear nerve deficiency in implanted ears or severe cochlear malformation
- Children already having spoken language who score better than 25th percentile on the Words and Sentences portion of the CDI language evaluation
Where in United States
- Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United StatesContact: Nancy Young, MDTaking people
About the trial
What the trial wants to find out
The language outcome of children receiving cochlear implantation to address bilateral sensorineural hearing loss is more variable than that of typical hearing children. The research is focused upon development of neural predictive models based upon brain imaging to forecast language after cochlear implantation on the individual child level. The long-term goal is improving children's language by using predictive models to enable a custom "predict to prescribe" approach to intervene with more effective behavioral therapy for children at risk to develop poorer language. The investigators previously developed models for short term language outcome of English-learning implanted children. The aims of this study are to 1. Develop models able to predict long term outcome for English- learning and Spanish-learning children; and 2. To evaluate whether English-learning children predicted to achieve lower language based on the investigators' previously constructed models can demonstrate significant gains from Parent Implemented Communication Treatment (PICT). PICT is an intensive parent education program about strategies to improve children's communication.
The 2 groups in the trial
- Non-treatment Model BuildingNo study treatment, for comparison
- Communication TreatmentTreatment being tested
Terminated
Treatment: Parent-Implemented Communication Treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neural Prediction to Enhance Language Outcomes in Children With Cochlear Implant
- Plain-language title
- Parent-led communication program for young children with cochlear implants and hearing lossGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 2 July 2026